Johnson MD - Search Results

1

Phase II evaluation of thalidomide in patients with metastatic breast cancer.

Baidas SM, Winer EP, Fleming GF, Harris L, Pluda JM, Crawford JG, Yamauchi H, Isaacs C, Hanfelt J, Tefft M, Flockhart D, Johnson MD, Hawkins MJ, Lippman ME, Hayes DF. Baidas SM, et al. Among authors: johnson md. J Clin Oncol. 2000 Jul;18(14):2710-7. doi: 10.1200/JCO.2000.18.14.2710. J Clin Oncol. 2000. PMID: 10894870 Clinical Trial.

2

Growth factors in breast cancer: mitogenesis to transformation.

Dickson RB, Johnson MD, Bano M, Shi E, Kurebayashi J, Ziff B, Martinez-Lacaci I, Amundadottir LT, Lippman ME. Dickson RB, et al. Among authors: johnson md. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):69-78. doi: 10.1016/0960-0760(92)90189-p. J Steroid Biochem Mol Biol. 1992. PMID: 1525068 Review.

3

A novel matrix-degrading protease in hormone-dependent breast cancer.

Dickson RB, Shi YE, Johnson MD. Dickson RB, et al. Among authors: johnson md. Biochem Soc Trans. 1994 Feb;22(1):49-52. doi: 10.1042/bst0220049. Biochem Soc Trans. 1994. PMID: 8206274 Review. No abstract available.

4

Breast cancer: influence of endocrine hormones, growth factors and genetic alterations.

Dickson RB, Johnson MD, el-Ashry D, Shi YE, Bano M, Zugmaier G, Ziff B, Lippman ME, Chrysogelos S. Dickson RB, et al. Among authors: johnson md. Adv Exp Med Biol. 1993;330:119-41. doi: 10.1007/978-1-4615-2926-2_10. Adv Exp Med Biol. 1993. PMID: 8368129 Review. No abstract available.

5

The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.

Thompson EW, Brünner N, Torri J, Johnson MD, Boulay V, Wright A, Lippman ME, Steeg PS, Clarke R. Thompson EW, et al. Among authors: johnson md. Clin Exp Metastasis. 1993 Jan;11(1):15-26. doi: 10.1007/BF00880062. Clin Exp Metastasis. 1993. PMID: 8380760

6

The role of cathepsin D in the invasiveness of human breast cancer cells.

Johnson MD, Torri JA, Lippman ME, Dickson RB. Johnson MD, et al. Cancer Res. 1993 Feb 15;53(4):873-7. Cancer Res. 1993. PMID: 8428368

7

Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.

Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG. Kurebayashi J, et al. Among authors: johnson md. Cancer Res. 1993 May 1;53(9):2178-87. Cancer Res. 1993. PMID: 8481921

8

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, Dickson R, Sale M, Rasmussen HS, Chiodo TA, Hawkins MJ. Wojtowicz-Praga S, et al. J Clin Oncol. 1998 Jun;16(6):2150-6. doi: 10.1200/JCO.1998.16.6.2150. J Clin Oncol. 1998. PMID: 9626215 Clinical Trial.

9

Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness.

Johnson MD, Torri JA, Lippman ME, Dickson RB. Johnson MD, et al. Exp Cell Res. 1999 Feb 25;247(1):105-13. doi: 10.1006/excr.1998.4336. Exp Cell Res. 1999. PMID: 10047452 Free article.

10

Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays.

Rae JM, Johnson MD, Lippman ME, Flockhart DA. Rae JM, et al. Among authors: johnson md. J Pharmacol Exp Ther. 2001 Dec;299(3):849-57. J Pharmacol Exp Ther. 2001. PMID: 11714868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,208 results

Search Page